Skip to main content

INTEGRATED BIOPHARMA INC

corporate_fare Company Profile

INTEGRATED BIOPHARMA INC

INBP·OTC·Consumer Defensive·CIK 0001016504

Integrated BioPharma, Inc. manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products. The company's customers are primarily located in the United States and Luxembourg. Integrated BioPharma, Inc. was originally incorporated on August 31, 1995, as Chem International, Inc., changed its name to Integrated Health Technologies, Inc. on December 5, 2000, and then to Integrated BioPharma, Inc. on January 29, 2003. The company continues to operate as Chem International, Inc. with some customers and vendors. The company has two business segments: (a) Contract Manufacturing, operated by Manhattan Drug Company, Inc. (MDC), which produces vitamins and nutritional supplements for distributors, multilevel marketers, and specialized health-care providers. (b) Other Business Lines, which includes: (i) MDC Warehousing and Distribution, Inc., providing warehousing and fulfillment services. (ii) Chem International, Inc. (Chem), which distributes certain raw materials for DSM Nutritional Products LLC and is the company's holding entity. (iii) All other inactive subsidiaries. In the fiscal years ended June 30, 2025, and 2024, approximately 84% and 90%, respectively, of the company's consolidated net sales came from two customers in the Contract Manufacturing Segment: Life Extension Quality Supplements and Vitamins, Inc. (Life Extension) and Herbalife Nutrition LTD (Herbalife). Life Extension and Herbalife accounted for approximately 62% and 26%, respectively, of the Contract Manufacturing Segment's net sales in the fiscal year ended June 30, 2025, and 71% and 23%, respectively, in the fiscal year ended June 30, 2024.

INTEGRATED BIOPHARMA INC (OTC:INBP) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors INBP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • INTEGRATED BIOPHARMA Reports Significant Quarterly and Nine-Month Losses Amidst Steep Revenue Decline
  • Long-Term 5%+ Shareholder Group Exits Position Due to Estate Transfer
  • Damon DeSantis Group Consolidates 41.3% Controlling Stake in Integrated BioPharma
  • Subsidiary Amends Lease with Related Party, Increasing Annual Rent by 30% for Less Space
  • Integrated BioPharma Reports Steep Q2 Loss and Revenue Decline, Bolstered by Strong Operating Cash Flow

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$54.35M
Net Income
$808K
Diluted EPS
$0.03
Op. Cash Flow
$2.06M
Free Cash Flow
$1.87M
Gross Profit
$5.56M
Operating Income
$2.02M
Cash & Equivalents
$3.62M
Debt / Equity
0.00×
Net Margin
1.5%
Shares Outstanding
31.06M sh
Source: 10-K · filed 2025-09-23 · accession 0001437749-25-029711
Browse all tickers starting with I →
$0.1807
52-week range · as of 2026-05-08 $0.205 – $0.42
Market cap
$5.61M
Volume
2.9K (0.3× avg)
3-mo avg 11.6K
Live data · 2026-06-14 05:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INBP - Latest Insights

INBP
May 08, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.250
Real-time Price: $0.18075 info
Change: -$0.06925 (-28%) info
Market Cap: $5.614M info
INBP
Apr 17, 2026, 4:17 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.280622
Real-time Price: $0.18075 info
Change: -$0.099872 (-36%) info
Market Cap: $5.614M info
INBP
Apr 17, 2026, 3:48 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $0.280622
Real-time Price: $0.18075 info
Change: -$0.099872 (-36%) info
Market Cap: $5.614M info
INBP
Feb 18, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.2987
Real-time Price: $0.18075 info
Change: -$0.11795 (-39%) info
Market Cap: $5.614M info
INBP
Feb 11, 2026, 4:24 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.300
Real-time Price: $0.18075 info
Change: -$0.11925 (-40%) info
Market Cap: $5.614M info